Lexaria Bioscience releases Series A and B Warrants

Lexaria Bioscience Corp. filed documents for Series A and B Common Stock Purchase Warrants allowing holders to purchase shares of common stock through specific dates in 2026. The securities are not registered with the SEC and may be offered or sold pursuant to an exemption or in a transaction not subject to the registration requirements of the Securities Act.